Russia expects to produce between 1.5 million and 2 million doses per month of its potential Covid-19 vaccine by the year end, gradually ramping up production to 6 million doses a month, according to Reuters.

Large-scale testing of the vaccine, developed by Moscow’s Gamaleya institute, is due to start in Russia next week.